Skip to Main Content

Editor’s note: A recording of the conversation is embedded below.

Every week, STAT+ subscribers get access to exclusive conversations with biotech, pharma, and health tech leaders. This week, STAT health tech correspondent Erin Brodwin will be joined by Glen Tullman, executive chairman and CEO of Transcarent. Coming off the success of Livongo, Tullman will discuss his new ideas for revamping employer-based health, and of course be taking your questions live.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED

Create a display name to comment

This name will appear with your comment